Pharmacovigilance is defined by the World Health Organization (WHO) as:
The science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.
The main objectives of pharmacovigilance in accordance with the applicable EU legislation are:
- Preventing harm from adverse reactions in humans.
- Promoting the safe and effective use of medicinal products, in particular by providing timely information about the safety of medicinal products for patients, healthcare professionals and the public.
Pharmacovigilance is therefore an activity contributing to the protection of patient and public health.
Related link:
National Organization for Medicines
Contact details for Pharmacovigilance of Chiesi Hellas:
Adverse Events reporting – Information Notice: All the information and personal data you will share with us on email will be protected and kept confidential in line with company policies and local privacy regulations including the Regulation (EU) 2016/679. Please note that Chiesi Farmaceutici SpA will process your personal data as Data Controller. The information you provide will be used for the purpose of drug safety surveillance and it may be shared with health authorities or involved third parties. You have a right of access to your personal data which we hold about you. You may exercise other privacy rights (such as right to rectify, limit or erase your personal data, as applicable) established per relevant privacy regulation. For more information on details of processing your personal data please see Data Controller’s privacy policy at https://www.chiesi.com/privacy/
Tel
Fax 
Email